Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04035486
Brief Title: A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2) (FLAURA2)

First Submitted : June 27, 2019
First Submitted that Met QC Criteria : July 25, 2019
First Posted : July 29, 2019

Last Update Submitted that Met QC Criteria : October 13, 2021
Last Update Posted : October 14, 2021